Carmona-Berrio David, Adarve-Rengifo Isabel, Marshall Andrea G, Vue Zer, Hall Duane D, Miller-Fleming Tyne W, Actkins Ky'Era V, Beasley Heather K, Almonacid Paula M, Barturen-Larrea Pierina, Wells Quinn S, Lopez Marcos G, Garza-Lopez Edgar, Dai Dao-Fu, Shao Jianqiang, Neikirk Kit, Billings Frederic T, Curci John A, Cox Nancy J, Gama Vivian, Hinton Antentor, Gomez Jose A
Vanderbilt University, Cell and Developmental Biology, Nashville, TN 37232, USA.
Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
iScience. 2024 Jul 24;27(9):110436. doi: 10.1016/j.isci.2024.110436. eCollection 2024 Sep 20.
Abdominal and thoracic aortic aneurysms (AAAs, TAAs) remain a major cause of deaths worldwide, in part due to the lack of reliable prognostic markers or early warning signs. Sox6 has been found to regulate renin controlling blood pressure. We hypothesized that Sox6 may serve as an important regulator of the mechanisms contributing to hypertension-induced aortic aneurysms. Phenotype and laboratory-wide association scans in a clinical cohort found that SOX6 gene expression is associated with aortic aneurysm in subjects of European ancestry. Sox6 and tumor necrosis factor alpha (TNF-α) expression were upregulated in aortic tissues from patients affected by either AAA or TAA. In Sox6 knockout mice with angiotensin-II-induced AAA, we found that Sox6 plays critical role in the development and progression of AAA. Our data support a regulatory role of SOX6 in the development of hypertension-induced AAA, suggesting that Sox6 may be a therapeutic target for the treatment of aortic aneurysms.
腹主动脉瘤和胸主动脉瘤(AAAs、TAAs)仍然是全球范围内主要的死亡原因之一,部分原因是缺乏可靠的预后标志物或早期预警信号。已发现Sox6可调节控制血压的肾素。我们推测Sox6可能是导致高血压性主动脉瘤的机制的重要调节因子。在一个临床队列中进行的表型和全实验室关联扫描发现,SOX6基因表达与欧洲血统受试者的主动脉瘤相关。在受AAA或TAA影响的患者的主动脉组织中,Sox6和肿瘤坏死因子α(TNF-α)的表达上调。在血管紧张素II诱导的AAA的Sox6基因敲除小鼠中,我们发现Sox6在AAA的发生和发展中起关键作用。我们的数据支持SOX6在高血压性AAA发展中的调节作用,表明Sox6可能是治疗主动脉瘤的治疗靶点。